Company patents

Afton Chemical Corporation

Afton Chemical Corporation's patent strategy reveals a surprising, albeit small, focus on pharma_biotech, with 5.8% of its portfolio in both 'Acyclic / Cyclic Compounds (Other Elements)' and 'Acyclic / Carbocyclic Compounds', despite its core business. While 'Acyclic / Cyclic Compounds (Other Elements)' saw a 100.0% YoY growth in 2024, its subsequent decline by 75.0% in 2025 and 100.0% so far in 2026, alongside similar declines in other categories, suggests a shifting priority away from these areas.

Patent Trend by Technology Area

Yearly patent publications since 2023

Product themes

Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.

121 US filings (since 2023) · 5 categories · 2 themes

Patents

Showing 1-10 of 167

Page 1 of 17